Quote | Super Quote
22977 MBFOPHA@EC2411A (CALL)
RT Nominal unchange0.010 0.000 (0.000%)

30/09/2024 13:36

{A-shares Focus}FOSUN PHARMA reached upper price limit

[ET Net News Agency, 30 September 2024] A-shares of FOSUN PHARMA (SH:600196) rose 10%
to RMB27.66. It hits the upper price limit of RMB27.67, and an intra-day low of RMB25.8.
The total shares traded was 47.58 million, with a value of RMB1.27b. The volume ratio is
4.9, and the turnover rate is 2.2%.
H-shares of FOSUN PHARMA (02196) rose 9.5% to HK$15.62. It hits an intra-day high of
HK$15.66, and hits an intra-day low of HK$14.84. The total shares traded was 12.99
million, with a value of HK$197.38m. The active buy/sell ratio is 54:46, with net buying
turnover of HK$15.45m. A-shares of FOSUN PHARMA has premium of 96.5% over H-shares.(ed)

Back to Related News

Remark: Real time quote last updated: 04/11/2024 12:28
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.